SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Waddell, L.
Right arrow Articles by Taylor, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waddell, L.
Right arrow Articles by Taylor, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A new self-rating scale for detecting atypical or second-generation antipsychotic side effects

L. Waddell

Southern General Hospital, Glasgow, UK, dickenslinda{at}hotmail.com

M. Taylor

Springpark Centre, Glasgow, UK

We aimed to construct and assess a new self rating scale to detect the side effects of second generation antipsychotics. This scale was designed to allow a timely, sensitive and reliable method of gathering information on the number and severity of side effects an individual suffers from. The Glasgow Antipscyhotic Side-effect Scale (GASS) was developed after literature review, discussion with members of the mental health team and with service user feedback. Fifty indivudals taking second generation antipsychotics completed the GASS along with the Liverpool Univeristy Neuroleptic Side Effect Rating Scale, and one week later completed the GASS for a second time. Fifty comparison subjects also completed the GASS. The GASS was shown to have good discrimatory power and construct validity, along with good re-test reliablity, and is put forward as a short, helpful and valid clinical tool.

Key Words: neuroleptic drugs • atypical antipsychotics • antipsychotic agents/adverse effects • drug monitoring • questionnaires

Journal of Psychopharmacology, Vol. 22, No. 3, 238-243 (2008)
DOI: 10.1177/0269881107087976
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Br. J. PsychiatryHome page
P. M. Haddad, M. Taylor, and O. S. Niaz
First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies
The British Journal of Psychiatry, November 1, 2009; 195(52): S20 - S28.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
L. Waddell and M. Taylor
Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review
The British Journal of Psychiatry, November 1, 2009; 195(52): S43 - S50.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
R. Gray, R. Spilling, D. Burgess, and T. Newey
Antipsychotic long-acting injections in clinical practice: medication management and patient choice
The British Journal of Psychiatry, November 1, 2009; 195(52): S51 - S56.
[Abstract] [Full Text] [PDF]


Advertisement